The Partnership is enabling targeted research to augment our knowledge and understanding of cancer and related chronic diseases.
Desired outcomes by 2017:
- The Canadian Partnership for Tomorrow Project will be a well-recognized platform optimized for cancer and chronic disease research — with a particular emphasis on cancer and cardiovascular disease — and the enrolment of any eligible Canadian wishing to participate will be facilitated
- Co-ordinated cancer research investments and associated actions will maximize the impact of research across the entire cancer control spectrum
Research is critical to the continued enhancement of our understanding of cancer and related chronic diseases, providing insights and applications that will enhance prevention, treatment and quality of life. Canada is fortunate to have many cancer research funders that support a wide range of research across the country and work together to ensure that significant gaps are addressed and that the impact of existing research investments is maximized. Supporting collaboration to ensure that this continues requires ongoing effort and commitment.
The Partnership is ideally positioned to play this catalyst role in two ways: the first is convening and planning to reduce duplication and maximize efficiencies; the second is investing in very targeted and specific research consistent with its unique mandate.
An example of targeted research in which the Partnership is acting as a catalyst is the Canadian Partnership for Tomorrow Project. Building on two regional studies, this innovative research initiative includes five regional partner projects: the B.C. Generations Project, Alberta’s Tomorrow Project, the Ontario Health Study, CARTaGENE in Quebec, and Atlantic PATH (Partnership for Tomorrow’s Health). All are collecting harmonized data and comparable samples to contribute to one large “population laboratory.” The Canadian Partnership for Tomorrow Project aims to recruit tens of thousands of Canadians and track them over time.
Funding for establishing this type of research platform is difficult to secure, but through support from the Partnership and regional partners, a solid base is being established. Between 2012 and 2017, the Partnership will continue to work collaboratively with partners to optimize the project platform to ensure that it can support research on cancer and related chronic diseases for many years to come.
Recognizing the value of strategic collaboration, major cancer research funders across Canada came together to form the Canadian Cancer Research Alliance, a network of over 30 research funding organizations. This alliance, together with researchers, patients and survivors, has created a common strategic agenda for collaborative initiatives between 2012 and 2017. The Partnership will continue to invest in this co-ordinated approach to maximize economies of scale, improve the overall efficiency of the Canadian cancer research funding system and amplify the impact of research investments across the country.
- Canadian Partnership for Tomorrow Project (priority initiative)
- Canadian Cancer Research Alliance
Find out more about the initiatives supporting this strategic priority in the Partnership’s 2012-2017 business plan.
- April 25, 2013: Strengthening Canada’s capability to conduct practice-changing clinical trials
- April 24, 2013: New report on trends in Canadian cancer research investment now available
- July 25, 2012: Terry Fox Research Institute launches pan-Canadian network to find better tools to treat prostate cancer